Comprehensive Clinical Development Services for Successful Drug Development

Navigate the complexity of early clinical development

With more than 40 years’ experience as a clinical research organization, NUVISAN offers the full range of solutions for Early Stage clinical drug development, which includes first-in-human clinical trials in healthy subjects and phase-I studies in a broader sense, i.e. all kind of pharmacokinetic studies (e.g., DDI, Food Interaction, Bioavailability, Bioequivalence, PK of Biosimilars) and pharmacodynamic studies as well as special safety studies (e.g., Thorough QT Trials). NUVISAN is also experienced in the conduct of clinical investigations with medical devices. We also support studies in special populations and patient studies with complex endpoints requiring partial hospitalization as well as additional PD-/surrogate and biomarkers. We support our clients with clinical study protocols and other essential study documents. Moreover, NUVISAN provides consulting services such as establishing clinical development plans and supporting regulatory procedures. We are familiar with regulatory requirements in Europe and can assist you with sample size calculations and planning the design elements and statistical evaluation of a clinical trial.